{
  "paper": {
    "doi": null,
    "pmcid": "PMC12758042",
    "title": "Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants",
    "authors": [],
    "journal": null,
    "year": null,
    "study_type": "narrative review",
    "eco_type": null
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "777544707e2808fd01d9cb8fbe5dc1d74b29532b",
      "git_commit_short": "7775447",
      "git_branch": "main",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:5bdf447f3cfe242d"
    },
    "execution": {
      "timestamp": "2026-02-27T16:09:01.134372Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 57.85
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "BRCA1_gene",
      "class": "Gene",
      "name": "BRCA1",
      "synonyms": [
        "BRCA1 DNA repair associated"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1100",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "BRCA2_gene",
      "class": "Gene",
      "name": "BRCA2",
      "synonyms": [
        "BRCA2 DNA repair associated"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1101",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pathogenic_variants",
      "class": "Mutation",
      "name": "pathogenic variants",
      "synonyms": [
        "pathogenic mutations"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "magnetic_resonance_imaging",
      "class": "Procedure",
      "name": "magnetic resonance imaging",
      "synonyms": [
        "MRI"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "selective_estrogen_receptor_modulators",
      "class": "Drug",
      "name": "selective estrogen receptor modulators",
      "synonyms": [
        "SERMs"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "tamoxifen",
      "class": "Drug",
      "name": "tamoxifen",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "10324",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "raloxifene",
      "class": "Drug",
      "name": "raloxifene",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "35035",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "exemestane",
      "class": "Drug",
      "name": "exemestane",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "69278",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "letrozole",
      "class": "Drug",
      "name": "letrozole",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "72965",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "denosumab",
      "class": "Drug",
      "name": "denosumab",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1043562",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "prophylactic_bilateral_mastectomy",
      "class": "Procedure",
      "name": "prophylactic bilateral mastectomy",
      "synonyms": [
        "PBM",
        "risk-reducing mastectomy",
        "RRM"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "risk_reducing_salpingo_oophorectomy",
      "class": "Procedure",
      "name": "risk-reducing salpingo-oophorectomy",
      "synonyms": [
        "RRSO"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "ovarian_cancer",
      "class": "Disease",
      "name": "ovarian cancer",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0029925",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "hereditary_breast_ovarian_cancer",
      "class": "Disease",
      "name": "hereditary breast and ovarian cancer",
      "synonyms": [
        "HBOC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "contralateral_breast_cancer",
      "class": "Disease",
      "name": "contralateral breast cancer",
      "synonyms": [
        "CBC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "transvaginal_ultrasound",
      "class": "Procedure",
      "name": "transvaginal ultrasound",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "germline_genetic_testing",
      "class": "Procedure",
      "name": "germline genetic testing",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cascade_testing",
      "class": "Procedure",
      "name": "cascade testing",
      "synonyms": [
        "family cascade testing"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "variants_uncertain_significance",
      "class": "Mutation",
      "name": "variants of uncertain significance",
      "synonyms": [
        "VUS"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "direct_to_consumer_testing",
      "class": "Procedure",
      "name": "direct-to-consumer genetic testing",
      "synonyms": [
        "DTC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "population_based_testing",
      "class": "Procedure",
      "name": "population-based testing",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "genetic_counseling",
      "class": "Procedure",
      "name": "genetic counseling",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cognitive_behavioral_therapy",
      "class": "Procedure",
      "name": "cognitive-behavioral therapy",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "mindfulness_based_interventions",
      "class": "Procedure",
      "name": "mindfulness-based interventions",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "RANK_RANKL_pathway",
      "class": "Pathway",
      "name": "RANK/RANKL pathway",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "sex_hormone_binding_globulin",
      "class": "Protein",
      "name": "sex hormone-binding globulin",
      "synonyms": [
        "SHBG"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "mammary_stem_cells",
      "class": "AnatomicalStructure",
      "name": "mammary stem cells",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_id:introduction:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "intro_1",
      "text": "Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:introduction:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "intro_2",
      "text": "These mutations greatly increase cancer risks, highlighting the critical need for more effective screening and prevention strategies.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:introduction:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "intro_3",
      "text": "Annual magnetic resonance imaging (MRI) remains the most sensitive screening tool for early breast cancer detection in high-risk individuals.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:screening:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "screening_1",
      "text": "There is a broad consensus that surveillance and early detection in high-risk women should be based on annual contrast-enhanced breast magnetic resonance imaging (MRI), which is considered the most sensitive test for early detection of breast cancer.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:rrs:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "rrs_1",
      "text": "Patients with BRCA1 or BRCA2-mutated carriers are advised to consider prophylactic bilateral mastectomy (PBM) which has been shown to reduce the incidence of breast cancer by approximately 90%.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:rrs:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "rrs_2",
      "text": "In addition to decreasing the incidence of ovarian cancer, many studies have documented an added beneficial effect of risk-reducing BSO.",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:chemoprevention:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "chemo_1",
      "text": "Tamoxifen or raloxifene was relatively short, with only 90 participants (44.6%) using it beyond 4 years and 61 (30.2%) using it for less than 2 years.",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_id:chemoprevention:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_id",
      "text_span_id": "chemo_2",
      "text": "After a mean follow-up of 6.8 years, breast cancer was diagnosed among 22 (10.9%) tamoxifen/raloxifene users and 71 (14.3%) among non-users (HR: 0.64; 95% CI: 0.40 - 1.03; P = 0.07).",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "narrative review",
      "eco_type": null,
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "BRCA1_gene",
      "predicate": "INCREASES_RISK",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:introduction:1:llm",
        "paper_id:introduction:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRCA2_gene",
      "predicate": "INCREASES_RISK",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:introduction:1:llm",
        "paper_id:introduction:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRCA1_gene",
      "predicate": "INCREASES_RISK",
      "object": "ovarian_cancer",
      "evidence_ids": [
        "paper_id:introduction:1:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRCA2_gene",
      "predicate": "INCREASES_RISK",
      "object": "ovarian_cancer",
      "evidence_ids": [
        "paper_id:introduction:1:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "introduction",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "magnetic_resonance_imaging",
      "predicate": "INDICATES",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:introduction:3:llm",
        "paper_id:screening:1:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {
        "sensitivity": "most sensitive"
      },
      "section": "screening",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "prophylactic_bilateral_mastectomy",
      "predicate": "TREATS",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:rrs:1:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {
        "risk_reduction": "90%"
      },
      "section": "risk_reducing_surgery",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "bilateral salpingo-oophorectomy",
      "predicate": "TREATS",
      "object": "ovarian_cancer",
      "evidence_ids": [
        "paper_id:rrs:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "risk_reducing_surgery",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "bilateral salpingo-oophorectomy",
      "predicate": "TREATS",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:rrs:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.9,
      "properties": {
        "additional_benefit": "true"
      },
      "section": "risk_reducing_surgery",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "tamoxifen",
      "predicate": "TREATS",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:chemoprevention:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.85,
      "properties": {
        "hazard_ratio": "0.64"
      },
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "raloxifene",
      "predicate": "TREATS",
      "object": "breast cancer",
      "evidence_ids": [
        "paper_id:chemoprevention:2:llm"
      ],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.85,
      "properties": {
        "hazard_ratio": "0.64"
      },
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "selective_estrogen_receptor_modulators",
      "predicate": "SAME_AS",
      "object": "tamoxifen",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Tamoxifen is a type of SERM"
    },
    {
      "subject": "selective_estrogen_receptor_modulators",
      "predicate": "SAME_AS",
      "object": "raloxifene",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Raloxifene is a type of SERM"
    },
    {
      "subject": "aromatase inhibitors",
      "predicate": "SAME_AS",
      "object": "exemestane",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Exemestane is a type of aromatase inhibitor"
    },
    {
      "subject": "aromatase inhibitors",
      "predicate": "SAME_AS",
      "object": "anastrozole",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Anastrozole is a type of aromatase inhibitor"
    },
    {
      "subject": "aromatase inhibitors",
      "predicate": "SAME_AS",
      "object": "letrozole",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": "Letrozole is a type of aromatase inhibitor"
    },
    {
      "subject": "denosumab",
      "predicate": "ASSOCIATED_WITH",
      "object": "RANK_RANKL_pathway",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.9,
      "properties": {
        "mechanism": "disrupts RANKL/RANK-mediated stem cell stimulation"
      },
      "section": "chemoprevention",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "cognitive_behavioral_therapy",
      "predicate": "TREATS",
      "object": "anxiety",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.85,
      "properties": {},
      "section": "psychological_interventions",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "mindfulness_based_interventions",
      "predicate": "TREATS",
      "object": "anxiety",
      "evidence_ids": [],
      "source_papers": [
        "paper_id"
      ],
      "confidence": 0.85,
      "properties": {},
      "section": "psychological_interventions",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "This review focuses on unaffected carriers of BRCA1/BRCA2 pathogenic variants and their risk reduction strategies",
    "The paper emphasizes the importance of personalized counseling and culturally sensitive approaches",
    "Several ongoing clinical trials are mentioned, including the BRCA-P trial for denosumab and the French LIBER trial for letrozole"
  ]
}